Global Pen Needles Market is Expected to Worth at CAGR of 11.6% to 2024

Data Bridge Market Research new Insight’s on Global Pen Needles Market, is projected to reach USD 4.5 billion by 2024, from USD 1.9 billion in 2016, at a CAGR of 11.6% during the forecast period from 2017 to 2024.”

Access Full Report :  http://databridgemarketresearch.com/reports/global-pen-needles-market/

The market is segmented by Product Type (Standard Pen Needles, Safety Pen Needles) Product Length (Nano, Medium, Long) Usability (Reusable, Disposable) Application (Diabetes, Growth Hormone Deficiency, Others) Therapy (Insulin, Glucagon-like peptide-1, Growth Hormones) End-User (Hospitals, Clinics, OTC, Home Healthcare, Others) Geography (North America, Europe, APAC, South America, Row) – Industry Trends and Forecast to 2024

The actual calculation year for the report is 2016, while the historic data is for 2015 and the forecast period is still 2024.

Recent Developments: Global Pen Needles Market

Insulin pens are the easiest and safest way to deliver insulin. Insulin pens are basically used with pen needles, which are gaining popularity every day over conventional insulin delivery methods. The usage of pen needles in insulin delivery is increasing owing to its benefits such as more convenient as can be used while travelling, easier to use and can be handled by any one, dosage given is more accurate, pain free and better discretion. The global pen needles market is expected to grow significantly owing to rising prevalence of diabetes and other chronic diseases. There is a shortage of trained professionals in developed countries which is encouraging patients to use self-use products such as pen needles. According to the Center of Disease Control (CDC) in 2015, 11.9 percent of the U.S. population is suffering from diabetes which is increasing at 0.7 percent each year, however 83.2 percent are physician diagnosed and the remaining remains undiagnosed. The major risk of diabetes is its comorbidities related mortality increasing every year. The pen needles market is also expected to grow owing to increasing reimbursements of these products in developing countries such as China, India, and Brazil among others.

Segmentation: Global Pen Needles Market Categories

  • The Global Pen Needles Market is segmented into product type, product length, usability, application, therapy,  end-user, and geography.
  • Based on product type, the global pen needles market is segmented into standard and safety pen needles.
  • On the basis of usability, the global pen needles market is segmented into disposable and reusable pen needles.
  • Based on product length, the market is segmented into nano length, medium length, and long length.
  • On the basis of application, the global pen needles market is segmented into diabetes, growth hormone deficiency, and others.
  • Based on end-user the market is segmented into hospitals, clinics, OTC, home healthcare, and others.
  • Based on the drug therapy, the pen needles market is segmented into insulin, glucagon-like peptide-1, and growth hormones.

Geographic Segmentation: Global Pen Needles Market

Based on geography, the market is segmented into five geographical regions, North America, Europe, Asia-Pacific, South America and Rest of the World. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others. North America is expected to dominate the market with 42.3 percent market share in 2016, owing to the favorable reimbursement scenarios and increasing trend of self-injection injectable in this market.  Asia-Pacific is expected to grow at the highest CAGR of 13.7 percent spear headed by growth of China and India. The growth of these countries is owing to rising prevalence of diabetes and increasing awareness of health related needs.

Company Share Analysis: Global Pen Needles Market

The pen needles market is highly fragmented with various companies operating in local regions. The report includes company share data for different geographies including North America, Europe, South America, and Asia Pacific.

Some of the major players in the global market are :

  • Becton
  • Dickinson and Company
  • ADW Diabetes
  • Novo Nordisk
  • A.Menarini Diagnostics Ltd.
  • Ulticare
  • Ypsomed Holding AG
  • Facet Technologies
  • B. Braun Melsungen AG
  • Shanghai Neo-Medical Co. Ltd.
  • HTL-Strefa S.A.
  • Frank Healthcare Co., Ltd.
  • Stat Medical Devices, Inc.
  • Terumo Corporation
  • Domrex Pharma Inc.
  • Vogt Medical Vertrieb GmbH
  • Artsana S.p.A
  • Eli Lilly and Company
  • Owen Mumford Ltd.
  • KD Medical GmbH Hospital Products
  • Allison Medical, Inc.
  • Digital Medics Pty Ltd
  • Ultimed, Inc.
  • Among others.

Other Market Insights:

APAC Topical Drug Delivery Market, latest insights by Data Bridge Market Research says that the market is growing at a CAGR of 14.9% in the forecast period 2017 to 2024, expected to reach USD 34.1 billion by 2024

MORE INSIGHTS

Europe Cancer Biomarkers Market,latest insights by Data Bridge Market Research says that the new market reports contains actual calculation year for the report in 2016, while the historic data is for 2015 and the forecast period is 2017 to 2024.

MORE INSIGHTS